Phosphine

Phosphine

SCHEMBL6673547

CCCCc1ccc(CCl)c(CCCC)c1CCCC.P

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTRC Q99895 1/20 0.42
TYR P14679 3/20 0.41
HTT P42858 2/20 0.35
NPC1 O15118 1/20 0.35
HPGD P15428 1/20 0.35
MAPK1 P28482 1/20 0.35
RAB9A P51151 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
CYP3A4 P08684 2/20 0.35
TYMP P19971 2/20 0.35
MEN1 O00255 1/20 0.35
TP53 P04637 1/20 0.35
ALOX5 P09917 1/20 0.35
MAPT P10636 1/20 0.35
ALOX15 P16050 1/20 0.35
TSHR P16473 1/20 0.35
KMT2A Q03164 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
LIPG Q9Y5X9 1/20 0.32
SKP2 Q13309 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6413165 0.98 CTRC (0.43) CTRCTYRHTTNPC1HPGD
Ammonia Solution, Strong SCHEMBL995128 0.96 CTRC (0.42) CTRCTYRHTTNPC1HPGD
Phosphine SCHEMBL20163265 0.92 TYR (0.47) CTRCTYRHTTCYP3A4TYMP
Phosphine SCHEMBL1535934 0.92 TYR (0.47) CTRCTYRHTTCYP3A4TYMP
Ammonia Solution, Strong SCHEMBL7027226 0.88 TYR (0.47) CTRCTYRHTTCYP3A4TYMP
Ammonia Solution, Strong SCHEMBL3782696 0.88 TYR (0.47) CTRCTYRHTTCYP3A4TYMP
Ammonia Solution, Strong SCHEMBL20163276 0.88 TYR (0.47) CTRCTYRHTTCYP3A4TYMP
SCHEMBL30044969 0.87 TYR (0.50) CTRCTYRHTTNPC1HPGD
SCHEMBL4633219 0.87 TYR (0.50) CTRCTYRHTTNPC1HPGD
SCHEMBL2494501 0.80 PRKCI (0.33) HPGDTYMP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 80 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11859074-B2 Curable fluoroelastomer composition 3M INNOVATIVE PROPERTIES COMPANY (US) 2024-01-02 US claimed
US-20210292533-A1 CURABLE FLUOROELASTOMER COMPOSITION 3M INNOVATIVE PROPERTIES COMPANY 2021-09-23 US claimed
US-20210189111-A1 CURABLE FLUOROELASTOMER COMPOSITION 3M INNOVATIVE PROPERTIES COMPANY 2021-06-24 US claimed
EP-3837309-A1 CURABLE FLUOROELASTOMER COMPOSITION 3M Innovative Properties Company (US) 2021-06-23 EP claimed
EP-3807355-A1 CURABLE FLUOROELASTOMER COMPOSITION 3M Innovative Properties Company (US) 2021-04-21 EP claimed
EP-3775019-A1 BLENDS OF CROSSLINKING AGENTS FOR FLUOROELASTOMERS 3M Innovative Properties Company (US) 2021-02-17 EP claimed
EP-3755739-A1 CURABLE FLUOROELASTOMER COMPOSITION 3M Innovative Properties Company (US) 2020-12-30 EP claimed
EP-3755745-A1 BLENDS OF CROSSLINKING AGENTS FOR FLUOROELASTOMERS 3M Innovative Properties Company (US) 2020-12-30 EP claimed
EP-3755744-A1 CURABLE FLUOROELASTOMER COMPOSITION 3M Innovative Properties Company (US) 2020-12-30 EP claimed
US-20200369867-A1 CURABLE FLUOROELASTOMER COMPOSITION 3M INNOVATIVE PROPERTIES COMPANY 2020-11-26 US claimed
WO-2020035776-A1 CURABLE FLUOROELASTOMER COMPOSITION 3M INNOVATIVE PROPERTIES COMPANY (US) 2020-02-20 WO claimed
WO-2019197915-A1 BLENDS OF CROSSLINKING AGENTS FOR FLUOROELASTOMERS 3M INNOVATIVE PROPERTIES COMPANY (US) 2019-10-17 WO claimed
WO-2019159070-A1 CURABLE FLUOROELASTOMER COMPOSITION 3M INNOVATIVE PROPERTIES COMPANY (US) 2019-08-22 WO claimed
WO-2019159066-A1 BLENDS OF CROSSLINKING AGENTS FOR FLUOROELASTOMERS 3M INNOVATIVE PROPERTIES COMPANY (US) 2019-08-22 WO claimed
WO-2019159067-A1 CURABLE FLUOROELASTOMER COMPOSITION 3M INNOVATIVE PROPERTIES COMPANY (US) 2019-08-22 WO claimed
US-12509569-B2 Curable fluoropolymer compositions comprising metal fluoride particles and articles therefrom 3M INNOVATIVE PROPERTIES COMPANY (US) 2025-12-30 US disclosed
US-12428384-B2 Hydroxy-functionalized triazine compounds, curable fluoropolymer compositions comprising such compounds and cured articles therefrom 3M INNOVATIVE PROPERTIES COMPANY (US) 2025-09-30 US disclosed
EP-0139404-B1 BIOCIDAL WATER TREATMENT Albright & Wilson Limited (GB) 1988-02-03 EP disclosed
US-4673509-A ADDING PHOSPHONIUM COMPOUND ALBRIGHT & WILSON LIMITED (GB) 1987-06-16 US disclosed
EP-0139404-A1 Biocidal water treatment Albright & Wilson Limited (GB) 1985-05-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12428384-B2 Hydroxy-functionalized triazine compounds, curable fluoropolymer compositions comprising such compounds and cured articles therefrom ALKBH3, HDGF, UHRF1 CTRC 3071/4885TYR 1508/4885HTT 206/4885
US-12509569-B2 Curable fluoropolymer compositions comprising metal fluoride particles and articles therefrom TIAM1, CARM1, NPM1 CTRC 316/4885TYR 1683/4885HTT 4438/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.